Well that’s the risk we take with these pre revenue biotech stocks, glad to have a few others in my spec biotech portfolio that have done a fair bit better to average it out. They do have cash in the bank to keep things running so all the best to the LT holders who continue holding.
Order in the market and back to holiday mode (perhaps a few extra drinks today lol)
Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $94.66K | 10.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 661860 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1588275 | 6 |
View Market Depth
| Last trade - 15.52pm 27/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |